GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunogen Inc (NAS:IMGN) » Definitions » Cyclically Adjusted PB Ratio

Immunogen (Immunogen) Cyclically Adjusted PB Ratio : 135.78 (As of May. 26, 2024)


View and export this data going back to 1989. Start your Free Trial

What is Immunogen Cyclically Adjusted PB Ratio?

As of today (2024-05-26), Immunogen's current share price is $31.23. Immunogen's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was $0.23. Immunogen's Cyclically Adjusted PB Ratio for today is 135.78.

The historical rank and industry rank for Immunogen's Cyclically Adjusted PB Ratio or its related term are showing as below:

IMGN' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.53   Med: 9.16   Max: 135.78
Current: 135.45

During the past years, Immunogen's highest Cyclically Adjusted PB Ratio was 135.78. The lowest was 1.53. And the median was 9.16.

IMGN's Cyclically Adjusted PB Ratio is not ranked
in the Biotechnology industry.
Industry Median: 1.73 vs IMGN: 135.45

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Immunogen's adjusted book value per share data for the three months ended in Sep. 2023 was $2.113. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.23 for the trailing ten years ended in Sep. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Immunogen Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Immunogen's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunogen Cyclically Adjusted PB Ratio Chart

Immunogen Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 9.40 15.68 23.00 19.57

Immunogen Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.52 19.57 17.71 85.13 68.83

Competitive Comparison of Immunogen's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Immunogen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immunogen's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunogen's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Immunogen's Cyclically Adjusted PB Ratio falls into.



Immunogen Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Immunogen's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=31.23/0.23
=135.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunogen's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, Immunogen's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book=Book Value per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=2.113/129.8595*129.8595
=2.113

Current CPI (Sep. 2023) = 129.8595.

Immunogen Quarterly Data

Book Value per Share CPI Adj_Book
201312 1.519 98.326 2.006
201403 1.141 99.695 1.486
201406 0.881 100.560 1.138
201409 0.686 100.428 0.887
201412 0.900 99.070 1.180
201503 0.693 99.621 0.903
201506 0.405 100.684 0.522
201509 0.133 100.392 0.172
201512 -0.192 99.792 -0.250
201603 -0.472 100.470 -0.610
201606 -0.944 101.688 -1.206
201609 -1.403 101.861 -1.789
201612 0.000 101.863 0.000
201703 -1.875 102.862 -2.367
201706 -1.933 103.349 -2.429
201709 -0.963 104.136 -1.201
201712 -0.135 104.011 -0.169
201803 -0.273 105.290 -0.337
201806 0.599 106.317 0.732
201809 0.315 106.507 0.384
201812 0.073 105.998 0.089
201903 -0.185 107.251 -0.224
201906 -0.455 108.070 -0.547
201909 -0.576 108.329 -0.690
201912 -0.507 108.420 -0.607
202003 -0.024 108.902 -0.029
202006 -0.141 108.767 -0.168
202009 -0.246 109.815 -0.291
202012 0.459 109.897 0.542
202103 0.471 111.754 0.547
202106 0.342 114.631 0.387
202109 0.381 115.734 0.428
202112 1.478 117.630 1.632
202203 1.390 121.301 1.488
202206 1.132 125.017 1.176
202209 0.806 125.227 0.836
202212 0.689 125.222 0.715
202303 0.539 127.348 0.550
202306 1.974 128.729 1.991
202309 2.113 129.860 2.113

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Immunogen  (NAS:IMGN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Immunogen Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Immunogen's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Immunogen (Immunogen) Business Description

Industry
Traded in Other Exchanges
Address
830 Winter Street, Waltham, MA, USA, 02451
Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent.
Executives
Theresa Wingrove officer: VP of Regulatory Affairs IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451
Renee Lentini officer: V.P.-Fin., Prin. Acctg. Off. 830 WINTER STREET, WALTHAM MA 02451
Stacy Ann Coen officer: Chief Business Officer 11 RUSH POND RD, LAKEVILLE MA 02347
Kristine Peterson director AMARIN CORPORATION, MYSTIC PACKER BLDG., 12 ROOSEVELT AVENUE, MYSTIC CT 06355
Lauren White officer: SVP, CFO and PFO C4 THERAPEUTICS, INC., 490 ARSENAL WAY, SUITE 200, WATERTOWN MA 02472
Mark J Enyedy director, officer: Chief Executive Officer C/O FATE THERAPEUTICS, INC., 3535 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO CA 92121
Isabel Kalofonos officer: SVP & CHIEF COMMERCIAL OFFICER C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451
Michael Vasconcelles officer: EVP R&D & MEDICAL AFFAIRS C/O UNUM THERAPEUTICS, 200 CAMBRIDGEPARK DR., STE. 3100, CAMBRIDGE MA 02140
Daniel Char officer: SVP & CHIEF LEGAL OFFICER C/O EVELO BIOSCIENCES, INC., 620 MEMORIAL DRIVE, SUITE 200, CAMBRIDGE MA 02139
Kristen Harrington-smith officer: SVP & Chief Commercial Officer C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451
Tracey L Mccain director C/O BLUEPRINTS MEDICINES CORPORATION, 38 SIDNEY STREET, SUITE 200, CAMBRIDGE MA 02139
Helen M. Thackray director C/O GLYCOMIMETICS, INC., 401 PROFESSIONAL DRIVE, SUITE 250, GAITHERSBURG MD 20879
David G Foster officer: V.P.-Fin., Prin. Acctg. Off. C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451
Susan Altschuller officer: SVP and CFO 45 TENNYSON ST., SOMERVILLE MA 02145
Craig Barrows officer: Vice-President,General Counsel C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451